Management

Management

Alexander
Shneider,
Ph.D.


Founder and CEO


Over 25 years of biotech and entrepreneurial experience. Currently Senior Research Fellow of molecular biology at University of Ariel, Israel; editorial board member for journals Aging and Cell Cycle, advisor at We Fund Health. The past achievements and activities include but are not limited to drug development from concept to market authorization, patents in all major jurisdictions, advisory role for successful exits, consulting for Fortune 100 companies, establishing and leading international R&D consortia, senior authorship in papers and books.
Management

Mr.
Robert Devlin, D.V.M., M.B.A.
Legg


Executive Consultant



Management

Vlad
Gabai,
Ph.D.


VP of R&D


Over 30 years of successful discovery and development experience and problem-solving skills in R&D of anti-cancer drugs from bench to bedside. Over 80 papers, over 4,000 references. Past academic appointments with Boston University and Boston Biomedical Research Institute.
Management

Franco
Venanzi,
Ph.D.


Director of Basic Research


Over 30 years of biomedical research, over 20 years of tenured faculty professorship at University of Camerino, Italy, where was Head of the Translational Biology Laboratory, 20 years of service as editor-in-chief, editorial board member and a reviewer for vaccination and immunobiology journals.